STOCK MARKET BSE NSE

Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines in India: Sources

Another giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending.

Published: 15th July 2021 02:15 PM  |   Last Updated: 15th July 2021 02:15 PM   |  A+A-

A nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London. (Photo | AP)

A nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine . (Photo | AP)

By ANI

NEW DELHI: The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation for their COVID-19 vaccine so that application is processed well in time but pharma companies have not applied for the license yet.

According to the sources to ANI, drug regulators are talking to them, but they say we are working on it.

Another giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending.

As DCGI approved Moderna, Cipla will import the vaccines from the US but there has been no decision on legal indemnity so far.

Recently, Dr V K Paul, Member, Niti Aayog, said, "Talks initiatives, no reply has come from them. We are waiting for the process. Negotiations are on with a positive mind."

"We are in the process of trying to clinch it but there's back and forth as it's a negotiated process," told Dr V K Paul to ANI.

Moderna and Pfizer had sought indemnity which would ensure that they can't be booked in case of any adverse effect of the vaccine. 



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp